SensoDetect AB Logo

SensoDetect AB

Develops AI decision-support solutions for mental illness diagnostics.

SDET | SPGR

Overview

Corporate Details

ISIN(s):
SE0003037456 (+1 more)
LEI:
549300BPUMGJZ3N7QM92
Country:
Sweden
Address:
Arenagatan 31, 215 32 Malmö

Description

SensoDetect AB is a neurodiagnostics MedTech and artificial intelligence (AI) company that develops objective decision-support solutions for mental illness. Based on over 30 years of research in clinical psychoacoustics, the company's core technology analyzes Auditory Brainstem Response (ABR) signals to provide quantitative data on the brain's reaction to sound. This system is designed to assist healthcare professionals in the assessment of psychiatric disorders such as schizophrenia, ADHD, and autism, aiming to improve diagnostic accuracy and patient quality of life.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all SensoDetect AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for SensoDetect AB

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for SensoDetect AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-01-22 Johan Granath Other Other 1,223,955 183,593.25 SEK
2025-01-21 per-anders hedin Other Other 3,214,285 482,142.75 SEK
2025-01-21 Johan Möllerström Other Other 2,170,535 325,580.25 SEK
2025-01-21 Johan Möllerström Other Other 1,836,610 275,491.50 SEK
2025-01-21 Johan Möllerström Other Other 714,285 107,142.75 SEK
2025-01-21 Wendi Ma Other Other 66,392 9,958.80 SEK
2025-01-21 Per-Anders Hedin Other Other 43,050 6,457.50 SEK
2025-01-21 Wendi Ma Other Other 66,392 N/A

Peer Companies

Ceres Power Holdings PLC Logo
A developer of solid oxide technology for clean power and green hydrogen production.
United Kingdom
CWR
Certara, Inc. Logo
Accelerates drug development using biosimulation software, technology, and services.
United States of America
CERT
CervoMed Inc. Logo
A clinical-stage biotech developing treatments for age-related neurologic disorders.
United States of America
CRVO
Chabiotech Co.,Ltd. Logo
Develops cell/gene therapies and provides CDMO and bio-banking services.
South Korea
085660
CHAMPIONS ONCOLOGY, INC. Logo
A CRO providing end-to-end solutions to accelerate oncology drug development.
United States of America
CSBR
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Logo
A contract research organization supporting drug discovery and development.
United States of America
CRL
Chiome Bioscience Inc. Logo
Clinical-stage biotech company developing antibody-based therapeutics.
Japan
4583
Chordate Medical Holding AB Logo
Develops a patented, drug-free neuromodulation treatment for migraine and rhinitis.
Sweden
CMH
Chordia Therapeutics,Inc Logo
Clinical-stage biotech developing novel cancer therapies targeting RNA deregulation.
Japan
190A
Cibus, Inc. Logo
Develops and licenses plant traits using non-GMO precision gene-editing technology.
United States of America
CBUS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.